{"disease":{"id":"respiratory-infections","name":"respiratory infections"},"drugs":{"marketed":[{"drug_id":"cefoxitin","indication_name":"Lower respiratory tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cephalexin","indication_name":"Respiratory tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CEPHALEXIN","company_name":"","drug_phase":"marketed","molecular_target":"Penicillin-binding proteins (PBPs)","drug_class":"First-generation cephalosporin","quality_score":80,"revenue":null,"mechanism":"Cephalexin is a cephalosporin antibacterial drug."},{"drug_id":"cefoxitin-sodium","indication_name":"Lower respiratory tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CEFOXITIN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":21,"revenue":null,"mechanism":null},{"drug_id":"ceftazidime","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fortaz","generic_name":"CEFTAZIDIME","company_name":"Pai Holdings Pharm","drug_phase":"marketed","molecular_target":"","drug_class":"ceftazidime","quality_score":10,"revenue":null,"mechanism":"Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death."},{"drug_id":"amoxicillin-and-clavulanate","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amoxicillin and clavulanate","company_name":"GlaxoSmithKline","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Amoxicillin and Clavulanate Potassium is an antibacterial drug."},{"drug_id":"chembl-chembl3989564","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TOBRAMYCIN SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"cefuroxime-sodium","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CEFUROXIME SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Cefuroxime inhibits bacterial cell wall synthesis, acting as a bactericidal agent."},{"drug_id":"doxycycline","indication_name":"Respiratory tract infections caused by Mycoplasma pneumoniae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"doxycycline","indication_name":"Respiratory tract infections caused by Haemophilus influenzae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"doxycycline","indication_name":"Respiratory tract and urinary tract infections caused by Klebsiella species","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"doxycycline","indication_name":"Upper respiratory infections caused by Streptococcus pneumoniae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cephalexin","indication_name":"Respiratory tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CEPHALEXIN","company_name":"","drug_phase":"marketed","molecular_target":"Penicillin-binding proteins (PBPs)","drug_class":"First-generation cephalosporin","quality_score":80,"revenue":null,"mechanism":"Cephalexin is a cephalosporin antibacterial drug."}],"pipeline":[{"drug_id":"active","indication_name":"Respiratory Syncytial Virus Infections","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Active","generic_name":"active","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Sisunatovir","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"rv521","indication_name":"Respiratory Syncytial Virus Infections","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RV521","generic_name":"rv521","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"RV521 drug in capsules","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":12,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT05321433","title":"Tobacco Use and the Risk of COVID-19 and Adverse Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":757585,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04110314","title":"Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":430636,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT05525494","title":"Patient Portal Flu Vaccine Reminders (5)","phase":"NA","overall_status":"COMPLETED","enrollment_count":262085,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT07334795","title":"Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":259000,"lead_sponsor_name":"Intermountain Health Care, Inc.","has_results":false},{"nct_id":"NCT05535777","title":"Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":246295,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT05052190","title":"Patient Portal Flu Vaccine Reminders_RCT 4","phase":"NA","overall_status":"TERMINATED","enrollment_count":239567,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT07416266","title":"Lower Respiratory Tract Infections Managed in Primary Care in France","phase":"","overall_status":"COMPLETED","enrollment_count":230066,"lead_sponsor_name":"Hôpital Raymond Poincaré","has_results":false},{"nct_id":"NCT04533685","title":"Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3","phase":"NA","overall_status":"COMPLETED","enrollment_count":213773,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT03666026","title":"Patient Portal - Flu Reminder Recall","phase":"NA","overall_status":"COMPLETED","enrollment_count":164205,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04239521","title":"The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata","phase":"","overall_status":"COMPLETED","enrollment_count":51955,"lead_sponsor_name":"Momentum Data","has_results":false},{"nct_id":"NCT04609423","title":"Cod Liver Oil for Covid-19 Prevention Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":47210,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT04505098","title":"A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":39600,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT01155193","title":"Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany","phase":"","overall_status":"COMPLETED","enrollment_count":30804,"lead_sponsor_name":"AbbVie (prior sponsor, Abbott)","has_results":true},{"nct_id":"NCT07075029","title":"RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":28800,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04886596","title":"Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":26675,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06062264","title":"Patient Portal Flu Vaccine Reminders (RCT 6)","phase":"NA","overall_status":"COMPLETED","enrollment_count":22233,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT05238025","title":"MVA-BN-RSV Vaccine Trial","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":20419,"lead_sponsor_name":"Bavarian Nordic","has_results":true},{"nct_id":"NCT06764381","title":"Study of Viral Respiratory Infections","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06568432","title":"Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections","phase":"NA","overall_status":"RECRUITING","enrollment_count":19424,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05726084","title":"Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":16304,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT04663776","title":"Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform","phase":"","overall_status":"COMPLETED","enrollment_count":16000,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT03265028","title":"TRACE E-learning Implementation in Belgium","phase":"","overall_status":"COMPLETED","enrollment_count":15802,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT03739112","title":"Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12794,"lead_sponsor_name":"Medicago","has_results":true},{"nct_id":"NCT06620341","title":"A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":11900,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04605159","title":"A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":11194,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06534892","title":"An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10212,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03301051","title":"Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10160,"lead_sponsor_name":"Medicago","has_results":true},{"nct_id":"NCT04623047","title":"Infection Watch Study","phase":"","overall_status":"COMPLETED","enrollment_count":10034,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03627572","title":"RESCEU Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe in Infants","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT05024890","title":"The Impact of a School-based WASH Intervention on Child Health and School Attendance in Addis Ababa, Ethiopia","phase":"NA","overall_status":"COMPLETED","enrollment_count":7072,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04537663","title":"Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6112,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT04627623","title":"Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT05244356","title":"Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation","phase":"NA","overall_status":"COMPLETED","enrollment_count":5784,"lead_sponsor_name":"Clinical Research Centre, Malaysia","has_results":false},{"nct_id":"NCT06120153","title":"Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5700,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT04245800","title":"Home Testing of Respiratory Illness","phase":"","overall_status":"COMPLETED","enrollment_count":5233,"lead_sponsor_name":"Evidation Health","has_results":false},{"nct_id":"NCT05690516","title":"The Protective Effect of Mask Wearing Against Respiratory Tract Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":4575,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT03614676","title":"A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance","phase":"NA","overall_status":"COMPLETED","enrollment_count":4493,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06993753","title":"Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4350,"lead_sponsor_name":"Griffith University","has_results":false},{"nct_id":"NCT06715306","title":"Intravenous Versus Oral Treatment of the Main Acute Infections","phase":"NA","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT03299283","title":"Specimen Collection and Transport Workflow Evaluations for CLIA-waived Molecular Testing","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"BioFire Diagnostics, LLC","has_results":false},{"nct_id":"NCT05705440","title":"A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3855,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05217797","title":"Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community","phase":"NA","overall_status":"COMPLETED","enrollment_count":3717,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT03379194","title":"Routine Antibiotic Prescription Monitoring in Primary Care Physicians: A Nationwide Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":3426,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT07489846","title":"Xpert® ERP on the GeneXpert® System","phase":"","overall_status":"COMPLETED","enrollment_count":3200,"lead_sponsor_name":"Cepheid","has_results":false},{"nct_id":"NCT03979313","title":"A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3012,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07401979","title":"The Influence of Explainability and Integrability of AI-CDSS on Usage Behavior Among Primary Care Physicians","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT03931577","title":"Effectiveness of Improving Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Acute Cough","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2940,"lead_sponsor_name":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}